Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer florescence at transurethral resections of superficial bladder cancer

Voprosy Onkologii

Volumn 49, Issue 6, 2003, Pages 734-737

  Daniltchenko, D I ^a   Koenig, F ^a   Riedl, C ^a   Schnorr, D ^a   Valdman, A ^a   Al Shukri, S ^a   Loening, S A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; PHOTOSENSITIZING AGENT;

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER SURGERY; CYSTOSCOPY; FLUORESCENCE; HUMAN; ILLUMINATION; MAJOR CLINICAL STUDY; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION; BLADDER TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; LIGHT; METHODOLOGY; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; URETHRA;

AMINOLEVULINIC ACID; CYSTECTOMY; CYSTOSCOPY; FLUORESCENCE; HUMANS; LIGHT; NEOPLASM, RESIDUAL; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 4444231505     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Dougherty TJ. Photodynamic therapy // Photochem. Photobiol. - 1993. - Vol. 58. - P. 895-900.
2. Filbeck T., Roessler W., Knuechel R. et al. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid // J. Endourol. - 1999. - Vol. 13. - P. 117-121.
3. Kennedy J.C., Pettier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy // J. Photochem. Photobiol. B. - 1992. - Vol. 14. - P. 275-292.
4. Klan R., Loy V., Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder // J. Urol. - 1991. - Vol. 146 (2). - P. 316-318.
5. Koenig F., McGovern F. Fluorescence detection of bladder carcinoma // Urology. - 1997. - Vol. 50 (5). - P. 778-779.
6. Kohrmann K.U., Woeste M., Kappes J. Der Wert der transurethralen Nachresektion beim oberflachlichen Harnblasenkarzinom // Akt. Urol. - 1994. - Vol. 25. - P. 208-213.
7. Kriegmair M., Baumgartner R., Knuechel R. at al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid // Urology. - 1994. - Vol. 44. - P. 836-841.
8. Kriegmair M., Baumgartner R., Knuechel R. at al. Detection of bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence // J. Urol. - 1996. - Vol. 155. - P. 105-110.
9. Miller K., Weissbach L. Leitlinien zur Diagnostik und Therapie des Harnblasenkarzinoms // Urologe A. - 1998. - Vol. 37. - P. 440-457.
10. Riedl C.R., Plas E., Pfluger H. Fluorescence detection of bladder tumors with 5-amino-levulinic acid // J. Endourol. - 1999. - Vol. 13. - P. 755-759.
11. Vogeli T.A., Marx G., Ackermann R. Zur Notwendigkeit der Nachresektion beim urothelialen Blasenkarzinom als Kontrolle der Erstresektion // Urologe A. - 1992. - Vol. 31 (suppl. 1). - A 59.